更年期第一部分:血管运动症状 (I)
Peng-Hui Wang1, Szu-Ting Yang2, Wen-Hsun Chang3
1Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Female Cancer Foundation, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Taiwanese journal of obstetrics & gynecology
|March 6, 2025
概括
费索利内坦,一种新型的神经素3受体抗剂,显示出与更年期相关的中度至重度血管运动症状 (VMS) 治疗的前景. 临床试验证实了其安全性和有效性,尽管对不同人群需要进一步研究.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 更年期,以雌激素下降为特征,显著影响女性的健康,血管运动症状 (VMS) 影响高达80%的个体.
- VMS对身体,心理和社会福祉产生负面影响,持续超过7年.
- 对于VMS的传统激素疗法面临着益处风险辩论,引发了针对VMS病理生理学的非激素治疗的兴趣.
研究的目的:
- 审查在绝经妇女中管理中度至重度VMS的近期进展.
- 专注于fezolinetant的疗效和安全性,这是一种新型神经素3受体 (NK3R) 抗剂,作为VMS的非激素治疗.
- 讨论KNDy神经元通路在VMS中的作用和NK3R抗剂的治疗潜力.
主要方法:
- 最近的随机临床试验 (RCT) 的审查,包括SKYLIGHT 1,2,和4,评估Fezolinetant对VMS.
- 在东亚人群中评估fezolinetant的MONGLIGHTRCT的分析.
- 探索涉及Kisspeptin (Kp),神经素B (NKB) 和激素 (DYN) 神经元 (KNDy神经元) 在温度调节和VMS中的神经生物学机制.
主要成果:
- 三个主要的RCT (SKYLIGHT 1,2,4) 证明了fezolinetant在治疗中度至重度VMS的安全性和有效性.
- 蒙格莱特RCT表明,在东亚人群中具有潜在的有争议的治疗效果,但证实了安全性.
- 费索利内坦特通过准中央温度调节电路,在非荷尔蒙性VMS管理方面取得了重大突破.
结论:
- 费索利内坦是更年期妇女中适度至重度VMS的有前途的非激素治疗剂.
- 虽然通常是安全和有效的,但需要进一步的RCT来验证不同人群的疗效.
- 通过NK3R对抗性准KNDy神经元通路为管理更年期血管运动症状提供了一种新的方法.
相关概念视频
01:18Disorders of the Autonomic Nervous System
512
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
512
01:17Hormonal Regulation of Blood Pressure
2.3K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.3K
01:22Hormonal Regulation of the Menstrual Cycle
255
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
255
01:24Disorders of the Female Reproductive System
290
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
290
01:28Menopause
112
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
112
01:23Assessment of the Cardiovascular System I: Subjective Data
257
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
257